Key facts
- It has raised $6.8M; the latest was Seed Round ($6.8M) in Feb 2025.
- Notable investors include SOSV, Entrepreneurs First, HAX, Anorak Ventures, Redalpine — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Level Zero
- ·The full record, as it builds
Funding rounds
No funding rounds for Level Zero are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Level Zero
Developer of biosensor technology intended for precise monitoring of key endocrine biomarkers. The company's platform leverages a minimally invasive wearable device with DNA-based sensors to continuously monitor hormone levels in real-time, enabling users with data and insights into their hormonal health.
- Sector
- Healthcare
- HQ
- Dover, DE, United States
- Founded
- 2023
- Employees
- 5
- Website
- levelzerohealth.com/
- Ownership
- Privately Held (backing)
Level Zero doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Level Zero shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Level Zero in its N-PORT filings yet. We sweep new filings monthly.